Sun Pharmaceutical Industries
₹1,801.00Change from previous close: −0.86%Absolute change: −₹15.60
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- ₹4.32T
- Enterprise value
- ₹4.04T
- P/E (trailing 12 months)
- 35.8
- Forward P/E
- 27.9
- PEG
- 1.04
- Price/book
- 5.17
- Price/sales
- 7.21
- EV/EBITDA
- 24.3
- EV/revenue
- 6.74
Profitability and growth
- Gross margin
- 78.9%
- Operating margin
- 23.2%
- Net margin
- 20.2%
- Revenue growth (year over year)
- 10.5%
- Earnings growth (year over year)
- 27.4%
Financial health
- Total cash
- ₹335.17B
- Total debt
- ₹46.27B
- Debt/equity
- 0.06
Dividends
- Annual dividend per share
- ₹16.00
- Dividend yield
- 0.9%
- Payout ratio
- 31.8%
- Ex-dividend date
- July 7, 2026
Analysts and estimates
- Average price target
- ₹2,175.59
- Median price target
- ₹2,165.00
- High price target
- ₹2,400.00
- Low price target
- ₹1,830.00
- Analysts with a price target
- 32
- Consensus
- Buy
- Forward EPS
- ₹64.54
- EPS estimate, current year
- ₹54.67
Shares and trading
- Beta
- 0.12
- Average volume
- 1.95M
- Shares outstanding
- 2.4B
- Float
- 1.06B
- Institutional ownership
- 29.4%
- Insider ownership
- 55.6%